Teleflex
Clinical trials sponsored by Teleflex, explained in plain language.
Teleflex
TFX
NYSE
Medical device company making catheters, surgical instruments, and respiratory products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New stent aims to clear long heart blockages safely Results expected Sep 2027 (estimated)